Triple
T12801457
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Phi Delta Theta |
E306027
|
entity |
| Predicate | hasPhilanthropyPartner |
P937
|
FINISHED |
| Object |
ALS Association
The ALS Association is a nonprofit organization dedicated to fighting amyotrophic lateral sclerosis (Lou Gehrig’s disease) through research, patient care, and public advocacy.
|
E1002936
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: ALS Association | Statement: [Phi Delta Theta, hasPhilanthropyPartner, ALS Association]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: ALS Association Context triple: [Phi Delta Theta, hasPhilanthropyPartner, ALS Association]
-
A.
Muscular Dystrophy Association
The Muscular Dystrophy Association is a nonprofit health organization dedicated to funding research, providing care, and offering support for individuals and families affected by muscular dystrophy and related neuromuscular diseases.
-
B.
Alzheimer’s Society
Alzheimer’s Society is a leading UK charity dedicated to supporting people affected by dementia and funding research to improve treatment, care, and ultimately find a cure.
-
C.
Alzheimer's and Related Disorders Association
The Alzheimer's and Related Disorders Association is a nonprofit organization dedicated to supporting research, advocacy, and care for individuals affected by Alzheimer's disease and other dementias.
-
D.
SMA Foundation
The SMA Foundation is a nonprofit organization dedicated to accelerating the development of treatments for spinal muscular atrophy through funding and collaborative research.
-
E.
Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research is a leading nonprofit organization dedicated to funding and accelerating scientific research aimed at finding a cure for Parkinson's disease and improving therapies for those living with it.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: ALS Association Triple: [Phi Delta Theta, hasPhilanthropyPartner, ALS Association]
Generated description
The ALS Association is a nonprofit organization dedicated to fighting amyotrophic lateral sclerosis (Lou Gehrig’s disease) through research, patient care, and public advocacy.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: ALS Association Target entity description: The ALS Association is a nonprofit organization dedicated to fighting amyotrophic lateral sclerosis (Lou Gehrig’s disease) through research, patient care, and public advocacy.
-
A.
Muscular Dystrophy Association
The Muscular Dystrophy Association is a nonprofit health organization dedicated to funding research, providing care, and offering support for individuals and families affected by muscular dystrophy and related neuromuscular diseases.
-
B.
Alzheimer’s Society
Alzheimer’s Society is a leading UK charity dedicated to supporting people affected by dementia and funding research to improve treatment, care, and ultimately find a cure.
-
C.
Alzheimer's and Related Disorders Association
The Alzheimer's and Related Disorders Association is a nonprofit organization dedicated to supporting research, advocacy, and care for individuals affected by Alzheimer's disease and other dementias.
-
D.
SMA Foundation
The SMA Foundation is a nonprofit organization dedicated to accelerating the development of treatments for spinal muscular atrophy through funding and collaborative research.
-
E.
Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research is a leading nonprofit organization dedicated to funding and accelerating scientific research aimed at finding a cure for Parkinson's disease and improving therapies for those living with it.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69d7bdf366888190a8cccb982606889c |
completed | April 9, 2026, 2:55 p.m. |
| NER | Named-entity recognition | batch_69d96facb2d48190bc12efc00c9da360 |
completed | April 10, 2026, 9:46 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69f6850f9ae4819094599b48d8d3a074 |
completed | May 2, 2026, 11:13 p.m. |
| NEDg | Description generation | batch_69f685dd1a88819096e40711f10d898a |
completed | May 2, 2026, 11:16 p.m. |
| NED2 | Entity disambiguation (via description) | batch_69f68884ed348190a1b2c89b1d655fa9 |
completed | May 2, 2026, 11:28 p.m. |
Created at: April 9, 2026, 5:30 p.m.